D-0211-2018 Class III Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-0211-2018 was initiated by Akorn Inc on Dec 15, 2017 and is designated Class III. Reason for recall: CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer. The recall status is terminated (terminated Apr 10, 2019). Affected quantity: 4,885 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 17, 2018
Initiation Date
Dec 15, 2017
Termination Date
Apr 10, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,885 bottles

Product description

Gabapentin Oral Solution, 250 mg/5 mL (50 mg/mL) in a 470 mL amber-colored bottle, Rx Only. Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701. NDC: 50383-311-47

Reason for recall

CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.

Distribution pattern

Nationwide

Code information

Batch# 359774; Exp. 09/02/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0211-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0211-2018. Report a data issue: hello@regdatalab.com.